Evidence map›Paper›PMID 38038928›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

N-Terminomics/TAILS of Human Tumor Biopsies and Cancer Cell Lines.

Afshin Derakhshani, Mitchell Bulluss, Regan Penner, Antoine Dufour

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Afshin DerakhshaniMcCaig Institute for Bone and Joint Health, Snyder Institute for Chronic Diseases, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Mitchell BullussMcCaig Institute for Bone and Joint Health, Snyder Institute for Chronic Diseases, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Regan PennerMcCaig Institute for Bone and Joint Health, Snyder Institute for Chronic Diseases, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Antoine DufourMcCaig Institute for Bone and Joint Health, Snyder Institute for Chronic Diseases, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. antoine.dufour@ucalgary.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteases serve essential roles in numerous biological processes and signaling cascades by cleaving their substrates in a restricted manner or via degradation. It is important to determine which proteins are protease substrates and where their cleavage sites are located to characterize the impact of proteolysis on the molecular mechanisms of their substrates. N-terminomics is a branch of proteomics that enriches the N-terminal sequence of proteins. A proteome-wide collection of these sequences has been broadly applied to comprehend proteolytic cascades and for genome annotation. Terminal Amine Isotopic Labeling of Substrates (TAILS) is a combined N-terminomics and proteomics technique that has been applied for protein N-terminal characterization and quantification of natural and neo-N-termini of proteins using liquid chromatography and tandem mass spectrometry (LC-MS/MS). TAILS uses negative selection to enrich both original mature protein N-termini and neo-N-termini produced from proteolysis in a proteome labeled with isotopic tags. This approach has been applied to the investigation of protease function and substrate identification in cell culture systems, animal disease models, and, most recently, clinical samples such as blood and tumor tissues from cancer patients.

Indexed as

NeoplasmsProteomeAminesAnimalsBiopsyCell LineChromatography, LiquidHumansPeptide HydrolasesProteolysisTandem Mass SpectrometryAminesPeptide HydrolasesProteomeCancerMass spectrometryN-terminomicsProteaseProteomicsTAILSTumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.